Research Shows Potential for Breast Cancer Prevention in BRCA1-Driven Tumors
The drug denosumab, which blocks a bone gene, may also prevent breast cancer caused by a BRCA1 mutation. This already approved drug could be available quickly, and would be the first drug for breast cancer prevention.